Selected research
Market Structure
Global Cell Immortalization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cell Immortalization market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cell Immortalization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell Immortalization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Immortalization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cell Immortalization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cell Immortalization include Lonza, Thermo Fisher Scientific, JSR, Sartorius, Merck, AcceGen, Creative Biolabs, InSCREENex GmbH and BioIVT, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cell Immortalization market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Immortalization and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Immortalization revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Immortalization market size, projected growth trends, production technologies, key applications, and end-use industries.
Cell Immortalization Segment by Company
Lonza
Thermo Fisher Scientific
JSR
Sartorius
Merck
AcceGen
Creative Biolabs
InSCREENex GmbH
BioIVT
Krishgen Biosystems
Applied Biological Materials
REPROCELL Inc
FUJIFILM Wako Pure Chemical Corporation
Abace Biotechnology
CELLCOOK
Procell
Takara Bio
Corning
Evercyte
Cell Immortalization Segment by Type
Stem Cell Therapy
Cell Transplantation
Drug Transport
Others
Cell Immortalization Segment by Application
Pharmaceutical and Biopharmaceutical Company
Research Laboratory
Hospital
Other
Cell Immortalization Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Immortalization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Immortalization and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Immortalization.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Immortalization in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Immortalization industry.
Chapter 3: Detailed analysis of Cell Immortalization companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Immortalizationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Therapy
- Cell Transplantation
- Drug Transport
- Others
Applications
- Pharmaceutical and Biopharmaceutical Company
- Research Laboratory
- Hospital
- Other
Companies covered
- Lonza
- Thermo Fisher Scientific
- JSR
- Sartorius
- Merck
- AcceGen
- Creative Biolabs
- InSCREENex GmbH
- BioIVT
- Krishgen Biosystems
- Applied Biological Materials
- REPROCELL Inc
- FUJIFILM Wako Pure Chemical Corporation
- Abace Biotechnology
- CELLCOOK
- Procell
- Takara Bio
- Corning
- Evercyte
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cell Immortalization Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stem Cell Therapy
- 1.2.3 Cell Transplantation
- 1.2.4 Drug Transport
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Cell Immortalization Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biopharmaceutical Company
- 1.3.3 Research Laboratory
- 1.3.4 Hospital
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Cell Immortalization Growth Trends by Region
- 1.5.1 Global Cell Immortalization Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cell Immortalization Market Size by Region (2021-2026)
- 1.5.3 Cell Immortalization Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cell Immortalization Market Dynamics
- 2.1 Cell Immortalization Industry Trends
- 2.2 Cell Immortalization Industry Drivers
- 2.3 Cell Immortalization Industry Opportunities and Challenges
- 2.4 Cell Immortalization Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cell Immortalization Revenue by Company (2021-2026)
- 3.2 Global Cell Immortalization Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cell Immortalization Key Company Head office and Area Served
- 3.4 Global Cell Immortalization Company, Product Type & Application
- 3.5 Global Cell Immortalization Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cell Immortalization Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cell Immortalization Players Market Share by Revenue in 2025
- 3.6.3 2025 Cell Immortalization Tier 1, Tier 2, and Tier 3
4 Cell Immortalization Market by Type
- 4.1 Global Cell Immortalization Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cell Immortalization Market Size by Type (2021-2032)
- 4.3 Global Cell Immortalization Market Size Share by Type (2021-2032)
5 Cell Immortalization Market by Application
- 5.1 Global Cell Immortalization Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cell Immortalization Market Size by Application (2021-2032)
- 5.3 Global Cell Immortalization Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Lonza
- 6.1.1 Lonza Company Information
- 6.1.2 Lonza Business Overview
- 6.1.3 Lonza Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Lonza Cell Immortalization Product Portfolio
- 6.1.5 Lonza Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Thermo Fisher Scientific Cell Immortalization Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 JSR
- 6.3.1 JSR Company Information
- 6.3.2 JSR Business Overview
- 6.3.3 JSR Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 JSR Cell Immortalization Product Portfolio
- 6.3.5 JSR Recent Developments
- 6.4 Sartorius
- 6.4.1 Sartorius Company Information
- 6.4.2 Sartorius Business Overview
- 6.4.3 Sartorius Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sartorius Cell Immortalization Product Portfolio
- 6.4.5 Sartorius Recent Developments
- 6.5 Merck
- 6.5.1 Merck Company Information
- 6.5.2 Merck Business Overview
- 6.5.3 Merck Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Merck Cell Immortalization Product Portfolio
- 6.5.5 Merck Recent Developments
- 6.6 AcceGen
- 6.6.1 AcceGen Company Information
- 6.6.2 AcceGen Business Overview
- 6.6.3 AcceGen Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AcceGen Cell Immortalization Product Portfolio
- 6.6.5 AcceGen Recent Developments
- 6.7 Creative Biolabs
- 6.7.1 Creative Biolabs Company Information
- 6.7.2 Creative Biolabs Business Overview
- 6.7.3 Creative Biolabs Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Creative Biolabs Cell Immortalization Product Portfolio
- 6.7.5 Creative Biolabs Recent Developments
- 6.8 InSCREENex GmbH
- 6.8.1 InSCREENex GmbH Company Information
- 6.8.2 InSCREENex GmbH Business Overview
- 6.8.3 InSCREENex GmbH Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 InSCREENex GmbH Cell Immortalization Product Portfolio
- 6.8.5 InSCREENex GmbH Recent Developments
- 6.9 BioIVT
- 6.9.1 BioIVT Company Information
- 6.9.2 BioIVT Business Overview
- 6.9.3 BioIVT Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 BioIVT Cell Immortalization Product Portfolio
- 6.9.5 BioIVT Recent Developments
- 6.10 Krishgen Biosystems
- 6.10.1 Krishgen Biosystems Company Information
- 6.10.2 Krishgen Biosystems Business Overview
- 6.10.3 Krishgen Biosystems Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Krishgen Biosystems Cell Immortalization Product Portfolio
- 6.10.5 Krishgen Biosystems Recent Developments
- 6.11 Applied Biological Materials
- 6.11.1 Applied Biological Materials Company Information
- 6.11.2 Applied Biological Materials Business Overview
- 6.11.3 Applied Biological Materials Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Applied Biological Materials Cell Immortalization Product Portfolio
- 6.11.5 Applied Biological Materials Recent Developments
- 6.12 REPROCELL Inc
- 6.12.1 REPROCELL Inc Company Information
- 6.12.2 REPROCELL Inc Business Overview
- 6.12.3 REPROCELL Inc Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 REPROCELL Inc Cell Immortalization Product Portfolio
- 6.12.5 REPROCELL Inc Recent Developments
- 6.13 FUJIFILM Wako Pure Chemical Corporation
- 6.13.1 FUJIFILM Wako Pure Chemical Corporation Company Information
- 6.13.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
- 6.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Product Portfolio
- 6.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
- 6.14 Abace Biotechnology
- 6.14.1 Abace Biotechnology Company Information
- 6.14.2 Abace Biotechnology Business Overview
- 6.14.3 Abace Biotechnology Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Abace Biotechnology Cell Immortalization Product Portfolio
- 6.14.5 Abace Biotechnology Recent Developments
- 6.15 CELLCOOK
- 6.15.1 CELLCOOK Company Information
- 6.15.2 CELLCOOK Business Overview
- 6.15.3 CELLCOOK Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 CELLCOOK Cell Immortalization Product Portfolio
- 6.15.5 CELLCOOK Recent Developments
- 6.16 Procell
- 6.16.1 Procell Company Information
- 6.16.2 Procell Business Overview
- 6.16.3 Procell Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Procell Cell Immortalization Product Portfolio
- 6.16.5 Procell Recent Developments
- 6.17 Takara Bio
- 6.17.1 Takara Bio Company Information
- 6.17.2 Takara Bio Business Overview
- 6.17.3 Takara Bio Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Takara Bio Cell Immortalization Product Portfolio
- 6.17.5 Takara Bio Recent Developments
- 6.18 Corning
- 6.18.1 Corning Company Information
- 6.18.2 Corning Business Overview
- 6.18.3 Corning Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Corning Cell Immortalization Product Portfolio
- 6.18.5 Corning Recent Developments
- 6.19 Evercyte
- 6.19.1 Evercyte Company Information
- 6.19.2 Evercyte Business Overview
- 6.19.3 Evercyte Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Evercyte Cell Immortalization Product Portfolio
- 6.19.5 Evercyte Recent Developments
7 North America
- 7.1 North America Cell Immortalization Market Size (2021-2032)
- 7.2 North America Cell Immortalization Market Size by Type
- 7.2.1 North America Cell Immortalization Market Size by Type (2021-2026)
- 7.2.2 North America Cell Immortalization Market Size by Type (2027-2032)
- 7.2.3 North America Cell Immortalization Market Share by Type (2021-2032)
- 7.3 North America Cell Immortalization Market Size by Application
- 7.3.1 North America Cell Immortalization Market Size by Application (2021-2026)
- 7.3.2 North America Cell Immortalization Market Size by Application (2027-2032)
- 7.3.3 North America Cell Immortalization Market Share by Application (2021-2032)
- 7.4 North America Cell Immortalization Market Size by Country
- 7.4.1 North America Cell Immortalization Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cell Immortalization Market Size by Country (2021-2026)
- 7.4.3 North America Cell Immortalization Market Size by Country (2027-2032)
- 7.4.4 North America Cell Immortalization Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cell Immortalization Market Size (2021-2032)
- 8.2 Europe Cell Immortalization Market Size by Type
- 8.2.1 Europe Cell Immortalization Market Size by Type (2021-2026)
- 8.2.2 Europe Cell Immortalization Market Size by Type (2027-2032)
- 8.2.3 Europe Cell Immortalization Market Share by Type (2021-2032)
- 8.3 Europe Cell Immortalization Market Size by Application
- 8.3.1 Europe Cell Immortalization Market Size by Application (2021-2026)
- 8.3.2 Europe Cell Immortalization Market Size by Application (2027-2032)
- 8.3.3 Europe Cell Immortalization Market Share by Application (2021-2032)
- 8.4 Europe Cell Immortalization Market Size by Country
- 8.4.1 Europe Cell Immortalization Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cell Immortalization Market Size by Country (2021-2026)
- 8.4.3 Europe Cell Immortalization Market Size by Country (2027-2032)
- 8.4.4 Europe Cell Immortalization Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cell Immortalization Market Size (2021-2032)
- 9.2 China Cell Immortalization Market Size by Type
- 9.2.1 China Cell Immortalization Market Size by Type (2021-2026)
- 9.2.2 China Cell Immortalization Market Size by Type (2027-2032)
- 9.2.3 China Cell Immortalization Market Share by Type (2021-2032)
- 9.3 China Cell Immortalization Market Size by Application
- 9.3.1 China Cell Immortalization Market Size by Application (2021-2026)
- 9.3.2 China Cell Immortalization Market Size by Application (2027-2032)
- 9.3.3 China Cell Immortalization Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cell Immortalization Market Size (2021-2032)
- 10.2 Asia Cell Immortalization Market Size by Type
- 10.2.1 Asia Cell Immortalization Market Size by Type (2021-2026)
- 10.2.2 Asia Cell Immortalization Market Size by Type (2027-2032)
- 10.2.3 Asia Cell Immortalization Market Share by Type (2021-2032)
- 10.3 Asia Cell Immortalization Market Size by Application
- 10.3.1 Asia Cell Immortalization Market Size by Application (2021-2026)
- 10.3.2 Asia Cell Immortalization Market Size by Application (2027-2032)
- 10.3.3 Asia Cell Immortalization Market Share by Application (2021-2032)
- 10.4 Asia Cell Immortalization Market Size by Country
- 10.4.1 Asia Cell Immortalization Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cell Immortalization Market Size by Country (2021-2026)
- 10.4.3 Asia Cell Immortalization Market Size by Country (2027-2032)
- 10.4.4 Asia Cell Immortalization Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cell Immortalization Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cell Immortalization Market Size by Type
- 11.2.1 South America, Middle East & Africa Cell Immortalization Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cell Immortalization Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cell Immortalization Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cell Immortalization Market Size by Application
- 11.3.1 South America, Middle East & Africa Cell Immortalization Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cell Immortalization Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cell Immortalization Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cell Immortalization Market Size by Country
- 11.4.1 South America, Middle East & Africa Cell Immortalization Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cell Immortalization Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cell Immortalization Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cell Immortalization Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst